The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Central obesity measures of waist circumference and waist-to-hip ratio appear to be more accurate and consistent indicators of colorectal cancer incidence compared with BMI, according to a study ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons.

The World Bank’s most recent food security update shows that food price inflation rates pushed higher in 2024 in most ...

The days of washing down a hotdog with a fizzy drink – and some other sugary drinks – while watching sport at a prominent ...

Rep. David Schweikert applauded RFK’s concern about obesity and chronic disease, without mentioning his history of ...

Most community crisis services did not expand after the launch of the 988 Suicide & Crisis Lifeline, potentially blunting the ...

Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.